Psoriasis
Psoriasis
Psoriasis
Psoriasis
Year 3 MBBS
Dermatology
Dr Sharmila V S
Psoriasis
• Psoriasis – chronic, autoimmune, inflammatory ,
hyperproliferative disorder of skin.
• BUT it is not infectious.
• It is associated with a Strong family history
• It is often aggravated by triggering environmental
factors .
• Age of onset : any age from infancy to 8th decade of
life
Pathogenesis of Psoriasis
PNEUMONIC - TIMES
Types of Psoriasis
DANDRUFF
Difference between Scalp Psoriasis & Dandruff
• Sudden appearance of
discrete numerous 2-
5mm papules with
silvery scales on the
trunk.
• NO PLAQUES SEEN
• Common in children,
often preceded by
streptococcal infection
(pharyngitis)
Nail Changes in Psoriasis
• Pitting of nails
• Onycholysis – separation of distal nail plate from the
nail bed
• Subungual hyperkeratosis : subungual deposition of
keratin
• Salmon patches ( oil drop sign) of the nail bed :
yellow-orange discoloration seen via the nail plate
• Nail dystrophy - Crumbling of nail plate
• Transverse lines ( Beaus lines )
Pitting of Nails
(Common Nail change but not pathognomic)
Salmon patch (oil drop sign) – yellow orange
discoloration of nails – Pathognomic Nail Change
Onycholysis & subungual hyperkeratosis
• Severity assessed as
1. Mild : If BSA ( body surface area ) is involved <10%
2. Moderate : If BSA ( body surface area ) is involved >10% to
30%
3. Severe : If BSA ( body surface area ) is involved >30% or
erythrodermic / pustular psoriasis
Treatment of Psoriasis
• If < 10 % of body surface area ( BSA ) is involved
TOPICAL THERAPY
If phototherapy is
contraindicated or
TOPICAL THERAPY not compliant TOPICAL THERAPY
+ +
PHOTOTHERAPY SYSTEMIC THERAPY
Treatment of Psoriasis
Potency depends on
• Vehicles – ointments are more potent than creams
• Concentration : BVO 0.1% is more than BVO 0.05%
• Ingredient – betamethasone dipropionate is more
potent than betamethasone valerate
Topical therapy - corticosteroids
• BVO FS ( 0.1% ) is highly potent – then potency
decreases with 1:2, 1:4, 1:8 ( this is prepared in HKL
by mixing with aqueous cream )
Adverse effect :
• Short term side effects : burning, erythema
• Long term side effects : skin cancer, photoaging
• Oral psoralens – cause cataract
Systemic therapy
Methotrexate ( MTX ):
• Given once a week dosing, started with 5mg / week
& increased to 7.5mg / week
• Folic acid 1 mg is given on all other days except the
day of MTX.
• Do baseline LFT, RFT, CBC & then repeat every 3
months.
• Do baseline CXR and repeat once in 1-2 years
Systemic therapy
Indications of MTX
• Generalised plaque type
• Erythrodermic
• Pustular psoriasis
• Psoriatic arthritis
Systemic therapy
Retinoids ( Acitretin )
• Especially first choice in pustular psoriasis
Ciclosporin
• Monitor blood pressure every week
• Monitor serum creatinine once in 2 weeks or once in
a month
• Since ciclosporin causes hypertension &
nephrotoxicity.